Preclinical Research Preclinical studies with retatrutide have consistently demonstrated superior metabolic effects compared to GLP-1 monoagonists across obesity, diabetes, and NASH rodent models providing the mechanistic foundation for its subsequent clinical development
For example, liraglutide has been shown to improve neural function through multiple signaling pathways, whereas semaglutide appears to exert more pronounced effects on neuroinflammation and neural tissue remodeling [11, 84, 86]
Obesity Medicine Association resources include position statements on pharmacotherapy for obesity, practice guidelines, and continuing education materials
Clinical photo of an irregularly shaped, tan-brown macule in the right side of the posterior hard palate
Furthermore, drugs with higher lipophilicity are enriched among those with age-biased DILI reporting frequency [88]